Company Filing History:
Years Active: 2005
Title: Innovations of John Ea Shaw in Microfabrication Technology.
Introduction
John Ea Shaw is a notable inventor based in Middlesex, GB. He has made significant contributions to the field of microfabrication, particularly in the development of devices that enhance cellular manipulation. His innovative approach has led to advancements that could impact various applications in biotechnology and medicine.
Latest Patents
John Ea Shaw holds a patent for a microfabricated cell injector. This device features an injection wall and a cell injection needle that projects from the wall, designed for piercing cells suspended in a fluid. The needle is securely held within a housing defined by the internal surfaces of the injector. The housing includes an inlet for suspended cells to enter and an outlet for cells to exit via the injection needle. A cell propulsion device is integrated to propel cells towards the needle, ensuring that cells suspended in the fluid are effectively impelled towards the injection wall by the injection needle. This innovative design has the potential to enhance the efficiency of cell injection processes.
Career Highlights
John Ea Shaw is currently associated with AstraZeneca AB, where he continues to work on cutting-edge technologies in the field of biotechnology. His role at AstraZeneca allows him to collaborate with other experts in the industry and contribute to the development of innovative solutions.
Collaborations
Throughout his career, John has worked alongside talented individuals such as Andrew J Garman and David J Scanlon. These collaborations have fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
John Ea Shaw's contributions to microfabrication technology, particularly through his patented microfabricated cell injector, highlight his role as a significant inventor in the biotechnology sector. His work continues to pave the way for future innovations that could transform medical and biotechnological applications.